BIOGY stock forecast, quote, news & analysis

Momentum Indicator for BIOGY turns positive, indicating new upward trend

BIOGY saw its Momentum Indicator move above the 0 level on September 16, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator turned positive. In of the 35 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for BIOGY just turned positive on September 16, 2025. Looking at past instances where BIOGY's MACD turned positive, the stock continued to rise in of 25 cases over the following month. The odds of a continued upward trend are .

BIOGY moved above its 50-day moving average on September 16, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BIOGY crossed bullishly above the 50-day moving average on September 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

BIOGY broke above its upper Bollinger Band on September 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.443) is normal, around the industry mean (16.941). P/E Ratio (38.088) is within average values for comparable stocks, (73.534). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.959). BIOGY has a moderately high Dividend Yield (0.062) as compared to the industry average of (0.030). P/S Ratio (7.576) is also within normal values, averaging (45.936).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BIOGY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIOGY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock better than average.

BIOGY paid dividends on May 29, 2025